| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $88.6M | +15.7% |
| SG&A Expense | $25.8M | +9.8% |
| Operating Income | -$114.4M | -14.3% |
| Income Tax | $0 | — |
| Net Income | -$148.7M | -34.2% |
| EPS (Basic) | -$1.26 | -17.8% |
| EPS (Diluted) | -$1.26 | -17.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.9M | -44.1% |
| Current Assets | $47.9M | -42.5% |
| Total Assets | $137.9M | +7.5% |
| Current Liabilities | $20.0M | +8.2% |
| Total Liabilities | $190.5M | +66.2% |
| Stockholders' Equity | -$52.7M | -488.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.1M | -33.9% |
| Capital Expenditures | $1.6M | -31.1% |
| Investing Cash Flow | -$1.6M | -808.7% |
| Financing Cash Flow | $114.2M | +2433.5% |
| Free Cash Flow | -$99.7M | -31.9% |